BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32297836)

  • 1. Clozapine use - has practice changed?
    Rowntree R; Murray S; Fanning F; Keating D; Szigeti A; Doyle R; McWilliams S; Clarke M
    J Psychopharmacol; 2020 May; 34(5):567-573. PubMed ID: 32297836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of clozapine prescribing in a mental health service in New Zealand.
    Harrison J; Janlöv M; Wheeler AJ
    Pharm World Sci; 2010 Aug; 32(4):503-11. PubMed ID: 20526811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.
    Taylor DM; Young C; Paton C
    J Clin Psychiatry; 2003 Jan; 64(1):30-4. PubMed ID: 12590620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].
    Grolleau A; Cougnard A; Parrot M; Kalmi E; Desage A; Misdrahi D; Brun-Rousseau H; Verdoux H
    Encephale; 2007; 33(3 Pt 1):326-31. PubMed ID: 17675930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine Use in a Cohort of First-Episode Psychosis.
    Doyle R; Behan C; OʼKeeffe D; Masterson S; Kinsella A; Kelly A; Sheridan A; Keating D; Hynes C; Madigan K; Lawlor E; Clarke M
    J Clin Psychopharmacol; 2017 Oct; 37(5):512-517. PubMed ID: 28650930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the Starting of Clozapine Influence Coprescription of Other Medications?: A Study From India.
    Grover S; Naskar C; Chakrabarti S
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):148-154. PubMed ID: 33666401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
    Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
    Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund.
    Weinbrenner S; Assion HJ; Stargardt T; Busse R; Juckel G; Gericke CA
    Pharmacopsychiatry; 2009 Mar; 42(2):66-71. PubMed ID: 19308881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
    Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Outcomes in the Management of Refractory Psychosis.
    Krivoy A; Joyce D; Tracy D; Gaughran F; MacCabe J; Lally J; Whiskey E; Sarkar SN; Shergill SS
    J Clin Psychiatry; 2019 Sep; 80(5):. PubMed ID: 31556974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RAISE Connection Program: Psychopharmacological Treatment of People With a First Episode of Schizophrenia.
    Kreyenbuhl JA; Medoff DR; McEvoy JP; Smith TE; Hackman AL; Nossel IR; Dixon LB; Essock SM; Buchanan RW
    Psychiatr Serv; 2016 Dec; 67(12):1300-1306. PubMed ID: 27364816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of prescribing for schizophrenia: evidence from a national audit in England and Wales.
    Patel MX; Bishara D; Jayakumar S; Zalewska K; Shiers D; Crawford MJ; Cooper SJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):499-509. PubMed ID: 24491953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic and clinical variation in clozapine use in the United States.
    Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
    Psychiatr Serv; 2014 Feb; 65(2):186-92. PubMed ID: 24233347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
    Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
    CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing trends and safety of clozapine in an older persons mental health population.
    Law A; Croucher M
    Int Psychogeriatr; 2019 Dec; 31(12):1823-1829. PubMed ID: 30894236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine prescribing in a Canadian outpatient population.
    Alessi-Severini S; Le Dorze JA; Nguyen D; Honcharik P; Eleff M
    PLoS One; 2013; 8(12):e83539. PubMed ID: 24358290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with changes in hospitalisation in patients prescribed clozapine.
    Gee SH; Shergill SS; Taylor DM
    J Psychopharmacol; 2016 Aug; 30(8):819-25. PubMed ID: 27097730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delay in initiation of clozapine: a retrospective study from a tertiary care hospital in North India.
    Grover S; Hazari N; Chakrabarti S; Avasthi A
    Psychiatry Res; 2015 Mar; 226(1):181-5. PubMed ID: 25619433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Clozapine vs Other Second-Generation Antipsychotics on Hospitalization and Seclusion: A Retrospective Mirror-Image Study in a Japanese Public Psychiatric Hospital.
    Misawa F; Suzuki T; Fujii Y
    J Clin Psychopharmacol; 2017 Dec; 37(6):664-668. PubMed ID: 29045304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.